Chapter 3 - THE DEVICE THAT HAD ALREADY BEEN “REMOVED”
Mom underwent surgery that evening.
The operation lasted ninety minutes.
I spent every second imagining every possible disaster.
Richard called constantly.
I blocked him.
Then his attorney called.
Blocked.
Then Halcyon Health Ventures' general counsel.
That one made Jasmine Chen—my own attorney—very interested.
I had called Jasmine from the waiting room.
She arrived forty minutes later wearing sneakers and carrying two laptops.
“Why is Richard's employer calling you about your mother's surgery?”
“I don't know.”
“We're about to.”
The general counsel left a voicemail.
They wanted to “coordinate preservation of confidential proprietary materials.”
I stared at Jasmine.
“Proprietary materials?”
“The device.”
“My mother's body isn't a corporate storage cabinet.”
“I agree.”
The language told us everything.
Halcyon knew what the capsule was.
When surgery ended, Dr. Patel came out.
I stood.
“How is she?”
“Stable.”
I almost collapsed.
“The object?”
“Removed.”
“Can I see it?”
“Not directly.”
Because of the possibility of legal relevance, the hospital had sealed it under evidence-preservation procedures.
A photograph showed a small titanium cylinder slightly longer than my thumbnail.
One end was damaged.
The surface bore etched markings.
NX-41-073.
Jasmine photographed the image.
Dr. Patel continued:
“Your mother had significant inflammatory tissue around it.”
“Will she recover?”
“We expect improvement, but she will need monitoring.”
“Why was it there?”
“We cannot answer that medically.”
Mr. Tran entered.
“We identified the manufacturer.”
I knew before he said it.
Nexora Biomedical Systems.
A medical-device startup.
One of Halcyon Health Ventures' most heavily promoted investments.
Richard had mentioned Nexora hundreds of times.
Christmas dinners.
Conference calls.
A framed magazine cover in his office.
Three years earlier, he told me Nexora was going to “change geriatric medicine.”
I had never cared enough to ask how.
Jasmine searched corporate records.
Richard was not only an executive at Halcyon.
He personally owned equity options tied to Nexora’s valuation.
“How much?” I asked.
“If the company received full regulatory approval? Potentially millions.”
The room went cold.
Then Mr. Tran gave us the most important detail.
The serial number corresponded to a device assigned to an early human feasibility study.
Patient:
Tessa Moran.
Age 68.
Not Teresa Santos.
The records stated:
Device explanted successfully after 14 days.
Date of explant:
Eleven months earlier.
I stared.
“My mother has been carrying something the company officially says was removed almost a year ago.”
“Yes.”
“Then whoever documented the removal lied.”
“Yes.”
Jasmine leaned forward.
“Who was principal investigator?”
Mr. Tran checked.
“Dr. Malcolm Brenner.”
I recognized the name.
The surgeon Richard chose for Mom’s hernia operation.
My entire body went cold.
The “hernia surgery” had somehow placed an experimental device assigned to a different patient into my seventy-five-year-old mother.
Mom had never consented to a trial.
And the official record said the device had already been removed.
Richard had recognized it instantly.
This was not an administrative mistake.
The question was how much he knew.
Rosa answered part of that.
We met her the next morning in Jasmine’s office.
She was forty-two.
Former imaging technician.
She looked exhausted even though it was nine in the morning.
“I've been waiting fourteen months for this.”
“For what?”
“For someone outside their system to see the device.”
She had worked at St. Augustine.
During Teresa’s follow-up imaging, she noticed the capsule.
The study database said NX-41-073 had been removed.
Rosa assumed she had the wrong patient.
Then she checked Teresa’s chart.
No device listed.
No clinical trial consent.
No implant documentation.
Nothing.
“I reported it.”
“To whom?”
“Compliance.”
“What happened?”
“They told me to stop accessing the file.”
“Then?”
“Dr. Brenner called me into a meeting.”
“Was Richard there?”
She looked at me.
“Yes.”
My hands went cold.
“What did he say?”
“That I misunderstood the study records.”
“What else?”
“He asked whether I'd spoken to your mother.”
Mom’s warning suddenly made sense.
Rosa continued.
“I said no.”
“Why?”
“Because the meeting scared me.”
Richard had not threatened her directly.
He didn't need to.
He reminded her that Halcyon funded several departments in the hospital network.
Mentioned her performance review.
Mentioned her husband’s job at a vendor company.
Power delivered politely.
Two weeks later, Rosa was transferred.
Three months after that, eliminated during restructuring.
“Why didn't you go to authorities?”
“I did.”
She pulled out a folder.
A complaint filed with a federal regulatory hotline.
“What happened?”
“Nothing I could see.”
Jasmine scanned the reference number.
“We can trace it.”
Rosa looked at me.
“Your mother asked me one thing after I told her.”
“What?”
“If I thought Richard knew.”
“And?”
“I said yes.”
My stomach twisted.
“Why?”
“Because when I said the serial number, he corrected me.”
I stared.
“He knew the serial number?”
“One digit.”
Rosa had intentionally misstated it.
Richard corrected her automatically.
Only someone deeply familiar with the device assignment should have known.
There was more.
The Nexora trial had struggled.
Early complications.
Poor enrollment.
Investors nervous.
Halcyon needed positive data before a major financing round.
The original patient assigned NX-41-073 withdrew before implantation.
The device should have been destroyed or reassigned through proper documentation.
Instead, somehow, it ended up inside Teresa.
“Why Mom?” I asked.
Rosa shook her head.
“I don't know.”
That answer haunted me.
Then Jasmine found a financial connection.
Harbor Meridian Surgical Center—the clinic where Mom had her “hernia” procedure—received a $480,000 research-services payment from Nexora three weeks before Mom’s operation.
Who approved it?
Richard.
I stared at his digital signature.
Not proof he ordered the implant.
But no longer coincidence.
Then my phone buzzed.
Richard.
This time, I answered.
“Maya.”
His voice sounded exhausted.
“We need to talk.”
“Yes.”
Relief entered his voice.
“Finally.”
I continued:
“With Jasmine present.”
Silence.
“No attorneys.”
“Interesting request from a man whose company called me with general counsel.”
“This is family.”
“No.”
I looked at the device photograph.
“This stopped being family when my mother became patient NX-41-073.”
Richard stopped breathing.
Then he whispered:
“You don't understand what you're doing.”
“Tell me.”
“If you turn over that device, you could destroy hundreds of jobs.”
I almost laughed.
Not my mother.
Not her health.
Jobs.
Stock.
Company.
“Did you know it was inside her?”
Silence.
“Richard.”
“Maya—”
“Did. You. Know?”
He answered:
“I knew there had been a protocol deviation.”
My entire body went cold.
“What does that mean in normal English?”
“I knew the device had been implanted outside the original study plan.”
“In my mother?”
A pause.
“Yes.”
The world went quiet.
“You knew.”
“I didn't know they left it in.”
“But you knew they put it there.”
“Yes.”
“Did Mom consent?”
“Technically—”
“Did she know?”
Silence.
That was the answer.
I hung up.
Jasmine stared at me.
“Please tell me that call was recorded.”
I held up my phone.
Miami was in a jurisdiction where recording rules mattered, and Jasmine would determine what could legally be used.
But even if the recording itself became complicated, Richard had just admitted enough for me.
My marriage was over.
Then Jasmine's laptop chimed.
She had received documents from my company accountant.
“What?”
Her face changed.
“You asked me to look at whether Richard had any access to your business accounts.”
“Yes.”
“He does.”
“How?”
“You authorized him six years ago for emergency transfers.”
I remembered.
My father was dying.
I had been overwhelmed.
Richard offered to help.
“I forgot.”
“He didn't.”
Over six years, Richard had moved money out of my company.
Not millions at once.
Small transfers.
Consulting expenses.
Property-review fees.
Administrative services.
Total:
$612,400.
Destination accounts were connected to Halcyon consulting entities.
I stared.
“He wasn't controlling my spending because he thought I spent too much.”
“No.”
Jasmine looked at me.
“He was controlling it because he needed you not to look closely.”
My husband had mocked me for wanting to spend a few hundred dollars helping my mother.
Meanwhile, he had quietly pulled more than half a million dollars out of the company my father left me.
Then we found the memo attached to the largest transfer.
NEXORA CLINICAL SUPPORT.
My money had helped finance the company whose unauthorized device was burning inside my mother's body.
And suddenly Richard's desperation made perfect sense.
If the capsule became evidence, he wasn't only losing a company.
May you like
He might lose everything.
---
